Return to Main Menu
|
MUSC poised to increase research
capacity
by Mary
Helen Yarborough
Public
Relations
For 26 years, much of MUSC’s clinical research effort has been
facilitated by funding from National Institutes of Health (NIH) General
Clinical Research Centers (GCRC) grants.
Dr. Kathleen Brady
Based on a federal program established in 1960, GCRC-certified
facilities are specialized, Joint Commission on Accreditation of
Healthcare Organizations (JCAHO)-accredited patient care units that
facilitate patient-oriented research in a cost-effective manner for
NIH. GCRC grants range from $1 million to $6 million per year,
according to Kathleen Brady, M.D., Ph.D., the GCRC program director for
MUSC.
GCRC grants have supported important research initiatives across the
nation for years. At MUSC, GCRC has contributed to many research
projects, resulting in hundreds of peer-reviewed publications and
medical breakthroughs during the past 26 years.
Now, as MUSC seeks a renewal of GCRC grants in the fall, it also is
gearing up for the next level of NIH funding, the Clinical and
Translational Science Awards (CTSA), that will eventually replace the
GCRC grants to be phased out nationally during the next seven to eight
years.
While GCRC grants have represented a substantial NIH effort toward
encouraging clinical research by institutions, they have been
considered by some participants to be too narrowly focused. The next
level of NIH funding, which intends to marry clinical and basic
science, would come from the CTSA awards. These would expand
opportunities for research, and could increase the amount of the grant
award to MUSC to about $6 million a year. Within two years, MUSC hopes
to have put together a successful application for CTSA funding. Most of
the nation’s top research medical centers also are seeking CTSA funding.
While GCRC has resulted in significant research at MUSC, CTSA will
expand the research so that treatment reaches the bedside and research
findings benefit the community in a much shorter timeframe.
If MUSC is successful in obtaining a CTSA grant, the GCRC programs
would be merged under CTSA, Brady said.
Brady, a 22-year MUSC veteran, is a key member of the CTSA planning
committee for MUSC. She explained the significance of GCRC grants to
ongoing research programs at MUSC.
“We have about 100 protocols and we have 160 investigators who use GCRC
to support their research,” she said. “We are having to renew GCRC
grants and also try to get CTSA funding.”
GCRC funding helps to supply laboratory, biostatistical, nursing and
other support. It does not fund the salaries of the investigators or
researchers.
Some of the research that has resulted from recent GCRC grant studies
at MUSC include:
- Studies that demonstrated the protective qualities of
dietary flavonoids in oral cancer and cardiovascular disease;
- A novel approach to the identification of changes in
enzymes within the myocardium that contribute to heart failure;
- A study identifying a promising and novel pharmacologic
approach to the treatment of cocaine addiction;
- A study exploring the mechanistic connection between
stress, PTSD and alcohol use disorders, demonstrating a relationship
between an abnormal stress response and alcohol relapse in
alcohol-dependent individuals;
- A study demonstrating that cyclophosphamide improved
physiologic and symptom outcomes in individuals with scleroderma,
restrictive lung physiology, dyspnea, and evidence of inflammatory
interstitial lung disease; and
- Studies exploring Vitamin D during pregnancy and lactation
that have had a major impact in determining recommended Vitamin D
requirements.
“CTSA will be a larger, more encompassing award for a larger array of
research activities,” Brady explained.
Friday, July 28, 2006
Catalyst Online is published weekly,
updated
as needed and improved from time to time by the MUSC Office of Public
Relations
for the faculty, employees and students of the Medical University of
South
Carolina. Catalyst Online editor, Kim Draughn, can be reached at
792-4107
or by email, catalyst@musc.edu. Editorial copy can be submitted to
Catalyst
Online and to The Catalyst in print by fax, 792-6723, or by email to
catalyst@musc.edu. To place an ad in The Catalyst hardcopy, call Island
Publications at 849-1778, ext. 201.
|